Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
- PMID: 32176772
- PMCID: PMC7184452
- DOI: 10.1093/cid/ciaa272
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Abstract
Background: From December 2019 to February 2020, 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a serious outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China. Related clinical features are needed.
Methods: We reviewed 69 patients who were hospitalized in Union hospital in Wuhan between 16 January and 29 January 2020. All patients were confirmed to be infected with SARS-CoV-2, and the final date of follow-up was 4 February 2020.
Results: The median age of 69 enrolled patients was 42.0 years (interquartile range 35.0-62.0), and 32 patients (46%) were men. The most common symptoms were fever (60 [87%]), cough (38 [55%]), and fatigue (29 [42%]). Most patients received antiviral therapy (66 [98.5%] of 67 patients) and antibiotic therapy (66 [98.5%] of 67 patients). As of 4 February 2020, 18 (26.9%) of 67 patients had been discharged, and 5 patients had died, with a mortality rate of 7.5%. According to the lowest SpO2 during admission, cases were divided into the SpO2 ≥ 90% group (n = 55) and the SpO2 < 90% group (n = 14). All 5 deaths occurred in the SpO2 < 90% group. Compared with SpO2 ≥ 90% group, patients of the SpO2 < 90% group were older and showed more comorbidities and higher plasma levels of interleukin (IL) 6, IL10, lactate dehydrogenase, and C reactive protein. Arbidol treatment showed tendency to improve the discharging rate and decrease the mortality rate.
Conclusions: COVID-19 appears to show frequent fever, dry cough, and increase of inflammatory cytokines, and induced a mortality rate of 7.5%. Older patients or those with underlying comorbidities are at higher risk of death.
Keywords: Wuhan; coronavirus; pneumonia.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: [email protected].
Comment in
-
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.Clin Infect Dis. 2020 Jul 28;71(15):889-890. doi: 10.1093/cid/ciaa330. Clin Infect Dis. 2020. PMID: 32215618 Free PMC article. No abstract available.
Similar articles
-
Coronavirus disease 2019: a clinical review.Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4585-4596. doi: 10.26355/eurrev_202004_21045. Eur Rev Med Pharmacol Sci. 2020. PMID: 32373999 Review.
-
Clinical features and treatment of COVID-19 patients in northeast Chongqing.J Med Virol. 2020 Jul;92(7):797-806. doi: 10.1002/jmv.25783. Epub 2020 Apr 1. J Med Virol. 2020. PMID: 32198776 Free PMC article.
-
Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.J Clin Microbiol. 2020 Apr 23;58(5):e00187-20. doi: 10.1128/JCM.00187-20. Print 2020 Apr 23. J Clin Microbiol. 2020. PMID: 32161092 Free PMC article. Review.
-
Clinical Characteristics of Imported Cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu Province: A Multicenter Descriptive Study.Clin Infect Dis. 2020 Jul 28;71(15):706-712. doi: 10.1093/cid/ciaa199. Clin Infect Dis. 2020. PMID: 32109279 Free PMC article.
-
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585. JAMA. 2020. PMID: 32031570 Free PMC article.
Cited by
-
Device-Associated Infections in COVID-19 Patients: Frequency of Resistant Bacteria, Predictors and Mortality in Medellín, Colombia.Microorganisms. 2024 Mar 22;12(4):640. doi: 10.3390/microorganisms12040640. Microorganisms. 2024. PMID: 38674585 Free PMC article.
-
Assessment of olfactory recovery after COVID-19: cross-sectional study.Eur Arch Otorhinolaryngol. 2024 Apr 19. doi: 10.1007/s00405-024-08646-5. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 38641737
-
Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: The blues of post-COVID-19 world.Case Stud Chem Environ Eng. 2021 Jun;3:100093. doi: 10.1016/j.cscee.2021.100093. Epub 2021 Feb 21. Case Stud Chem Environ Eng. 2021. PMID: 38620798 Free PMC article.
-
[COVID-19: Neurological manifestations and complications during the acute phase of the disease].Bull Acad Natl Med. 2023 Jun 27. doi: 10.1016/j.banm.2023.02.014. Online ahead of print. Bull Acad Natl Med. 2023. PMID: 38620177 Free PMC article. Review. French.
-
A comprehensive review on pharmacologic agents, immunotherapies and supportive therapeutics for COVID-19.Narra J. 2022 Dec;2(3):e92. doi: 10.52225/narra.v2i3.92. Epub 2022 Dec 8. Narra J. 2022. PMID: 38449903 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous